Area of research
Molecular Biology · Hematology
Research interest
Research interests include Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Metabolism, Diabetes, and Cancer, and Microbial Natural Products and Biosynthesis.
Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation
Synthesis and formulation studies of griseofulvin analogues with improved solubility and metabolic stability
Comprehensive Genomic Characterization of Refractory Multiple Myeloma Reveals a Complex Mutational and Structural Landscape Associated with Drug Resistance
Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes
Strategies for improving the solubility and metabolic stability of griseofulvin analogues
Abstract 2283: Molecular signaling in multiple myeloma: association of RAS/RAF mutation status and MAPK pathway activation in primary myeloma patient biopsies
Targeted sequencing of relapsed/refractory myeloma patients identifies an enrichment of mutations in MAPK and Cereblon pathways
Targeted Sequencing of Relapsed/Refractory Myeloma Patients Identifies an Enrichment of Mutations in Cereblon and MAPK Pathways